EMILY GALVAN: Open Payments
NPI 1538867569 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,805 in 159 payments from 26 companies in 2025. Trend: 2023 $1,925 · 2024 $2,885 · 2025 $2,805
Food & beverage: $2,805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $401 |
| Axsome Therapeutics, Inc. | 19 | $337 |
| AstraZeneca Pharmaceuticals LP | 2 | $212 |
| Janssen Pharmaceuticals, Inc | 9 | $181 |
| Amgen Inc. | 17 | $181 |
| PFIZER INC. | 17 | $171 |
| Novartis Pharmaceuticals Corporation | 12 | $162 |
| Lundbeck LLC | 8 | $156 |
| Lilly USA, LLC | 11 | $152 |
| Novo Nordisk Inc | 6 | $117 |
Products named: Auvelity, AIRSUPRA, VRAYLAR, SPRAVATO, VYEPTI, LEQVIO, MOUNJARO, UBRELVY.
Industry payments across TX — which companies pay providers there.
